Abstract
It is still not clear whether intact lipid vesicles can cross the human skin. Some reports in the literature indicate that transfersomes® can cross the skin. Other reports suggest that intact liposomes cannot cross the skin. Of course, the composition of the various formulations has to be taken into consideration before making such assertions. The present review examines the use of vesicles- elastic liposomes and ethosomes- for transdermal drug delivery. Liposomes are micro- or nano-structures formed from a bilayer of lipid surrounding an aqueous core. Elastic liposomes differ from conventional liposomes because they contain edge activators (surfactants) which impart elasticity and deformability. Ethosomes are efficient in facilitating percutaneous drug penetration. They are structurally similar to conventional liposomes in the sense that they are prepared from phospholipids but different because they contain a high concentration of ethanol. Both elastic liposomes and ethosomes are increasingly being used for delivering low and high molecular weight drugs. In this review, several reports are presented showing the usefulness of these vesicles and mechanistic insight sought as to why they may be effective in certain cases.
Keywords: Elastic liposomes, ethosomes, transdermal, dermal, vesicles.
Current Pharmaceutical Design
Title:Current Status of Ethosomes and Elastic Liposomes in Dermal and Transdermal Drug Delivery
Volume: 22 Issue: 33
Author(s): Kevin Ita
Affiliation:
Keywords: Elastic liposomes, ethosomes, transdermal, dermal, vesicles.
Abstract: It is still not clear whether intact lipid vesicles can cross the human skin. Some reports in the literature indicate that transfersomes® can cross the skin. Other reports suggest that intact liposomes cannot cross the skin. Of course, the composition of the various formulations has to be taken into consideration before making such assertions. The present review examines the use of vesicles- elastic liposomes and ethosomes- for transdermal drug delivery. Liposomes are micro- or nano-structures formed from a bilayer of lipid surrounding an aqueous core. Elastic liposomes differ from conventional liposomes because they contain edge activators (surfactants) which impart elasticity and deformability. Ethosomes are efficient in facilitating percutaneous drug penetration. They are structurally similar to conventional liposomes in the sense that they are prepared from phospholipids but different because they contain a high concentration of ethanol. Both elastic liposomes and ethosomes are increasingly being used for delivering low and high molecular weight drugs. In this review, several reports are presented showing the usefulness of these vesicles and mechanistic insight sought as to why they may be effective in certain cases.
Export Options
About this article
Cite this article as:
Ita Kevin, Current Status of Ethosomes and Elastic Liposomes in Dermal and Transdermal Drug Delivery, Current Pharmaceutical Design 2016; 22 (33) . https://dx.doi.org/10.2174/1381612822666160511150228
DOI https://dx.doi.org/10.2174/1381612822666160511150228 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Selective Elevation of Circulating CCL2/MCP1 Levels in Patients with Longstanding Post-vaccinal Macrophagic Myofasciitis and ASIA
Current Medicinal Chemistry L-PRP/L-PRF in Esthetic Plastic Surgery, Regenerative Medicine of the Skin and Chronic Wounds
Current Pharmaceutical Biotechnology Potential Application of Non-flavonoid Phenolics in Diabetes: Antiinflammatory Effects
Current Medicinal Chemistry New Hybrid Scaffolds based on Hydrazinyl Thiazole Substituted Coumarin; As Novel Leads of Dual Potential; In Vitro α-Amylase Inhibitory and Antioxidant (DPPH and ABTS Radical Scavenging) Activities
Medicinal Chemistry The Role of Blood-Brain Barrier Studies in the Pharmaceutical Industry
Current Drug Metabolism Update on Anti-TNF-Alpha Treatment in Rheumatic Diseases
Current Drug Therapy Acetylcholinesterase Inhibitors and Drugs Acting on Muscarinic Receptors- Potential Crosstalk of Cholinergic Mechanisms During Pharmacological Treatment
Current Neuropharmacology Remodelling of the Ca2+ Toolkit in Tumor Endothelium as a Crucial Responsible for the Resistance to Anticancer Therapies
Current Signal Transduction Therapy Targeted Delivery of Anti-Inflammatory Agents to Tumors
Current Pharmaceutical Design Drug Targeting of Estrogen Receptor Signaling in the Cardiovascular System: Preclinical and Clinical Studies
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Recent Progress of Machine Learning in Gene Therapy
Current Gene Therapy Apoptosis-Inducing Activity of the S100A8/A9 Heterodimer
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Dynamic Role of Microparticles in Type 2 Diabetes Mellitus
Current Diabetes Reviews Effect of Aging on Metabolic Pathways in Endothelial Progenitor Cells
Current Pharmaceutical Design MDMA Administration and Heat Shock Proteins Response: Foreseeing a Molecular Link
Current Pharmaceutical Biotechnology Adverse Cardiovascular Effects of Antirheumatic Drugs: Implications for Clinical Practice and Research
Current Pharmaceutical Design Concurrence of Talaromycosis and Kaposi Sarcoma in an HIV-Infected Patient: A Case Report
Current HIV Research Cigarette Smoking and Angiogenesis: What is the Role of Endothelial Progenitor Cells?
Current Angiogenesis (Discontinued) Unravelling the Role of Infectious Agents in the Pathogenesis of Human Autoimmunity: The Hypothesis of the Retroviral Involvement Revisited
Current Molecular Medicine Effects on Cytokines and Histology by Treatment with the Ace Inhibitor Captopril and the Antioxidant Retinoic Acid in the Monocrotaline Model of Experimentally Induced Lung Fibrosis
Current Pharmaceutical Design